Lancet Global Health

Papers
(The H4-Index of Lancet Global Health is 73. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Bringing home manufacturing of medical products1301
Preventing pellagra during isoniazid preventive treatment674
Racism and health: the need for urgent action491
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)441
The future of the International Health Regulations416
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply411
The cause of nodding syndrome remains unknown398
Enhancing global cancer care for sexual and gender minority populations: regional perspectives and global implications394
The pneumonia challenge: time to end the global neglect327
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6302
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial272
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys260
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study235
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019226
Global patterns and trends in Kaposi sarcoma incidence: a population-based study212
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study212
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study210
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis209
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study202
Resolving the CD4-testing crisis to help end AIDS-related deaths199
Indonesia's first nationwide health screening programme189
Is now the time for revisiting supplements for pregnant women?189
The road to malaria elimination: why a robust surveillance system is imperative186
Expanding access to long-acting HIV therapy in low-income and middle-income countries185
Safe scale-up of simulation-based training for minimally invasive surgery184
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou183
Mpox vaccination strategies in DR Congo179
C-reactive protein: another addition to our armamentarium against tuberculosis?172
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr166
The drug drought in maternal health: an ongoing predicament160
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor155
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study142
The health status of Indonesia's provinces: the double burden of diseases and inequality gap133
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study133
Influenza vaccination in failing hearts129
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study128
Outcomes of rheumatic fever in Uganda: a prospective cohort study126
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial125
Physical inactivity: another casualty of climate change125
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis122
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m119
Using verbal autopsy to enhance mortality surveillance114
Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis113
Payment in arrears: a global health inequity that must be corrected106
Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine106
Lessons for future implementation of the E-MOTIVE bundle104
Experiences of an Israeli hospital in the management of repatriated civilian hostages103
Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of the COBIN open-label, cluster randomised trial101
Quality of inpatient paediatric and newborn care in district hospitals: WHO indicators, measurement, and improvement101
Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation100
Infertility—why the silence?99
Aedes albopictus invasion across Africa: the time is now for cross-country collaboration and control98
Switching antibiotic therapy from injectable to oral to optimise the duration of inpatient care for young infants presenting with moderate-mortality-risk signs of possible serious bacterial infection:96
Avoidable deaths through the primary prevention, early detection, and curative treatment of cancer worldwide: a population-based study95
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden91
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 202690
Using theory to understand how interventions work and inform future implementation88
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study88
Pregnancy in people who have survived Ebola virus disease88
Mpox: evidence for strengthening and sustaining global surveillance84
Addressing the social inequities of vaccination: an imperative to close the gap83
How to DREAMM and end HIV-related deaths83
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply82
Cervical cancer elimination: actions needed in the COVID-19 era80
Correction to Lancet Glob Health 2023; 11: e1978–8579
Correction to Lancet Glob Health 2022; 10: e1443–5279
Improving access to liposomal amphotericin B worldwide78
Correction to Lancet Glob Health 2015; 3: e19678
Correction to Lancet Glob Health 2025; 13: e2013–2678
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all78
Highlighting the need for investment and innovation in ART retention interventions75
Uncertainty in key population size estimates in sub-Saharan Africa75
Beyond malaria: can intermittent preventive treatment with sulphadoxine-pyrimethamine reduce the number of small vulnerable newborns globally?74
0.17831492424011